Given that lncRAP2 is adipose-specific and conserved in mice and in humans, it represents an attractive target to selectively modulate Igf2bp2 activity within fat tissue to treat or prevent the progression of obesity-linked diabetes. This evidence concerns the gene IGF2BP2 and obesity due to melanocortin 4 receptor deficiency.